Medicamen Biotech consolidated net profit declines 36.89% in the December 2025 quarter
Sales rise 3.92% to Rs 46.91 crore
Net profit of Medicamen Biotech declined 36.89% to Rs 2.19 crore in the quarter ended December 2025 as against Rs 3.47 crore during the previous quarter ended December 2024. Sales rose 3.92% to Rs 46.91 crore in the quarter ended December 2025 as against Rs 45.14 crore during the previous quarter ended December 2024. ParticularsQuarter EndedDec. 2025Dec. 2024% Var.Sales46.9145.14 4 OPM %9.3414.86 -PBDT3.946.09 -35 PBT2.113.88 -46 NP2.193.47 -37Powered by Capital Market - Live News
Disclaimer: No Business Standard Journalist was involved in creation of this content